Teleflex - נכסים נקיים למניה בודדת TFX

The market trend for Teleflex Incorporated (TFX) shares on the GURU.Markets platform, reaching 68.77, is supported by steady demand for urological and surgical devices in clinics worldwide. Growth for Teleflex Incorporated (TFX) is driven by the introduction of new catheters, synergy with Palette Life Sciences, and the success of the UroLift system. The business model's revenues are based on the sale of disposable consumables for vascular access and respiratory support devices.

Teleflex Incorporated (TFX) develops high-precision medical instruments by investing in a staff of elite engineers and rigorous quality control. These expenditures on intellectual capital and equipment form the basis of the company's net assets. The book value per share is calculated as the difference between all assets and liabilities, divided by the number of shares outstanding. This metric reflects the real value of an investor's stake in the event of business liquidation. By analyzing the book value per share, one can assess capital stability to ensure the long-term reliability of the issuer.